Table 1.
Demographics of recruited children
| Total number of patients (N=255) |
SA | UK | |||||
| Prednisolone base tablet (n=52) |
Prednisolone sodium phosphate syrup (n=37) |
Dexamethasone elixir (n=33) |
Prednisolone base tablet (n=38) |
Prednisolone sodium phosphate soluble tablet (n=42) |
Dexamethasone sodium phosphate solution (n=53) |
||
| Age (years) | Median | 4.5 | 4 | 3.5 | 5 | 4 | 3 |
| Range | (2–10) | (2–10) | (2–5.5) | (2.4–16) | (2–14) | (2–10) | |
| IQR | 3–6 | 3–5 | 3–4.75 | 3.38–7.5 | 3–7 | 2.5–5 | |
| Gender | Male (%) | 34 (65.4) | 18 (48.6) | 18 (54.5) | 22 (58) | 29 (69) | 28 (53) |
| Female (%) | 18 (34.6) | 19 (51.4) | 15 (45.5) | 16 (42) | 13 (31) | 25 (47) | |
| Weight (kg) | Median | 18 | 15 | 14 | 20 | 17.8 | 17 |
| Range | (10–35) | (10–30) | (10–21) | (11.5–77) | (10.3–80) | (12–48.7) | |
| Dose (mg/kg/day) | Median | 2 | 2 | 0.3 | 1.2 | 1.1 | 0.2 |
| Range | (1.5–2) | 2 | (0.2–0.4) | (1.2–2) | (0.4–2) | (0.1–0.6) | |
| Dose duration (day) | Median | 3 | 3 | 1 | 3 | 3 | 1 |
| Range | (1–5) | (3–5) | 1 | (1–5) | (1–5) | 1 | |
| Received oral steroids before | Yes | 24 | 20 | 0 | 29 | 27 | 18 |
| No | 28 | 17 | 33 | 9 | 15 | 35 | |
SA, Saudi Arabia.